Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Aditxt, Inc. ( (ADTX) ) is now available.
On March 21, 2025, Aditxt, Inc. hosted a corporate update featuring its CEO, Amro Albanna, and Saundra Pelletier, CEO of Evofem Biosciences, Inc., which is a strategic acquisition target. The update focused on recent achievements and strategic milestones, particularly highlighting Evofem’s commitment to women’s health through innovative products like Phexxi, a non-hormonal birth control, and SOLOSEC for bacterial vaginosis and trichomoniasis. The discussion underscored the ongoing partnership between Aditxt and Evofem, emphasizing the potential impact on women’s health globally and the strategic growth opportunities for both companies.
More about Aditxt, Inc.
YTD Price Performance: -79.70%
Average Trading Volume: 3,082,990
Technical Sentiment Signal: Strong Buy
Current Market Cap: $9.93M
See more insights into ADTX stock on TipRanks’ Stock Analysis page.